Charles River Laboratories International, Inc. RV6.F Stock
Charles River Laboratories International, Inc. Price Chart
Charles River Laboratories International, Inc. RV6.F Financial and Trading Overview
Contents
- Charles River Laboratories International, Inc. Price Chart
- Charles River Laboratories International, Inc. RV6.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Charles River Laboratories International, Inc.
- Q&A For Charles River Laboratories International, Inc. Stock
Charles River Laboratories International, Inc. stock price | 229.9 EUR |
Previous Close | 190.7 EUR |
Open | 190 EUR |
Bid | 190 EUR x 10000 |
Ask | 191.95 EUR x 10000 |
Day's Range | 190 - 190 EUR |
52 Week Range | 165.15 - 242.3 EUR |
Volume | 500 EUR |
Avg. Volume | 11 EUR |
Market Cap | 9.79B EUR |
Beta (5Y Monthly) | 1.341197 |
PE Ratio (TTM) | 21.15813 |
EPS (TTM) | 8.6 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 450.55 EUR |
RV6.F Valuation Measures
Enterprise Value | 12.79B EUR |
Trailing P/E | 21.15813 |
Forward P/E | 16.407598 |
PEG Ratio (5 yr expected) | 3.11 |
Price/Sales (ttm) | 2.392442 |
Price/Book (mrq) | 3.128293 |
Enterprise Value/Revenue | 3.126 |
Enterprise Value/EBITDA | 13.089 |
Trading Information
Charles River Laboratories International, Inc. Stock Price History
Beta (5Y Monthly) | 1.341197 |
52-Week Change | -1.42% |
S&P500 52-Week Change | 20.43% |
52 Week High | 242.3 EUR |
52 Week Low | 165.15 EUR |
50-Day Moving Average | 179.55 EUR |
200-Day Moving Average | 203.11 EUR |
RV6.F Share Statistics
Avg. Volume (3 month) | 11 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 51.18M |
Float | 50.61M |
Short Ratio | N/A |
% Held by Insiders | 0.97% |
% Held by Institutions | 99.00% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | April 1, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 12.13% |
Operating Margin (ttm) | 16.41% |
Gross Margin | 36.74% |
EBITDA Margin | 23.88% |
Management Effectiveness
Return on Assets (ttm) | 5.68% |
Return on Equity (ttm) | 17.20% |
Income Statement
Revenue (ttm) | 4.09B EUR |
Revenue Per Share (ttm) | 80.34 EUR |
Quarterly Revenue Growth (yoy) | 12.59% |
Gross Profit (ttm) | 1.46B EUR |
EBITDA | 977.24M EUR |
Net Income Avi to Common (ttm) | 496.34M EUR |
Diluted EPS (ttm) | 8.98 |
Quarterly Earnings Growth (yoy) | 10.90% |
Balance Sheet
Total Cash (mrq) | 201.59M EUR |
Total Cash Per Share (mrq) | 3.94 EUR |
Total Debt (mrq) | 3.17B EUR |
Total Debt/Equity (mrq) | 100.38 EUR |
Current Ratio (mrq) | 1.476 |
Book Value Per Share (mrq) | 60.736 |
Cash Flow Statement
Operating Cash Flow (ttm) | 626.39M EUR |
Levered Free Cash Flow (ttm) | 258.57M EUR |
Profile of Charles River Laboratories International, Inc.
Country | Germany |
State | MA |
City | Wilmington |
Address | 251 Ballardvale Street |
ZIP | 01887 |
Phone | 781 222 6000 |
Website | https://www.criver.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 20000 |
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Q&A For Charles River Laboratories International, Inc. Stock
What is a current RV6.F stock price?
Charles River Laboratories International, Inc. RV6.F stock price today per share is 229.9 EUR.
How to purchase Charles River Laboratories International, Inc. stock?
You can buy RV6.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Charles River Laboratories International, Inc.?
The stock symbol or ticker of Charles River Laboratories International, Inc. is RV6.F.
Which industry does the Charles River Laboratories International, Inc. company belong to?
The Charles River Laboratories International, Inc. industry is Diagnostics & Research.
How many shares does Charles River Laboratories International, Inc. have in circulation?
The max supply of Charles River Laboratories International, Inc. shares is 51.51M.
What is Charles River Laboratories International, Inc. Price to Earnings Ratio (PE Ratio)?
Charles River Laboratories International, Inc. PE Ratio is 26.73255500 now.
What was Charles River Laboratories International, Inc. earnings per share over the trailing 12 months (TTM)?
Charles River Laboratories International, Inc. EPS is 8.6 EUR over the trailing 12 months.
Which sector does the Charles River Laboratories International, Inc. company belong to?
The Charles River Laboratories International, Inc. sector is Healthcare.